BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7240967)

  • 1. Platelet lipid composition and platelet aggregation in human liver disease.
    Owen JS; Hutton RA; Day RC; Bruckdorfer KR; McIntyre N
    J Lipid Res; 1981 Mar; 22(3):423-30. PubMed ID: 7240967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
    Shattil SJ; Bennett JS; Colman RW; Cooper RA
    J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets.
    Osamah H; Mira R; Sorina S; Shlomo K; Michael A
    Br J Clin Pharmacol; 1997 Jul; 44(1):77-83. PubMed ID: 9241100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet hypersensitivity induced by cholesterol incorporation.
    Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
    J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease.
    Owen JS; Bruckdorfer KR; Day RC; McIntyre N
    J Lipid Res; 1982 Jan; 23(1):124-32. PubMed ID: 7057101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIa hypercholesterolemic subjects.
    Mosconi C; Colli S; Tremoli E; Galli C
    Atherosclerosis; 1988 Aug; 72(2-3):129-34. PubMed ID: 3214465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill.
    Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ
    Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia.
    Hiramatsu K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Jan; 6(1):49-57. PubMed ID: 7256794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition.
    Chetty N; Naran NH
    Clin Chim Acta; 1992 Dec; 213(1-3):1-13. PubMed ID: 1477981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition.
    Aviram M; Deckelbaum RJ
    Metabolism; 1989 Apr; 38(4):343-7. PubMed ID: 2725276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease.
    Watanabe M; Shiraishi K; Itakura M; Matsuzaki S
    Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):97S-102S. PubMed ID: 9622382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.
    Boberg M; Vessby B; Croon LB
    Atherosclerosis; 1985 Dec; 58(1-3):49-63. PubMed ID: 2936356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
    De Castro J; Hernández-Hernández A; Rodríguez MC; Sardina JL; Llanillo M; Sánchez-Yagüe J
    Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary (n--3) fatty acids on platelet function and lipid metabolism in rats.
    Nordøy A; Davenas E; Ciavatti M; Renaud S
    Biochim Biophys Acta; 1985 Jul; 835(3):491-500. PubMed ID: 2861854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered lipid composition and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinemia.
    Prisco D; Rogasi PG; Paniccia R; Coppo M; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Res; 1988 Jun; 50(5):593-604. PubMed ID: 3413721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid composition of guinea pig platelets and megakaryocytes. The megakaryocyte as a probable source of platelet lipids.
    Schick BP; Schick PK; Chase PR
    Biochim Biophys Acta; 1981 Jan; 663(1):239-48. PubMed ID: 7213767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary fatty acids on signal transduction and membrane cholesterol content in rat platelets.
    Heemskerk JW; Feijge MA; Simonis MA; Hornstra G
    Biochim Biophys Acta; 1995 Mar; 1255(1):87-97. PubMed ID: 7893743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil.
    Ahmed AA; Holub BJ
    Lipids; 1984 Aug; 19(8):617-24. PubMed ID: 6090856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.